The role of extracorporeal blood purification in correcting intoxication markers in septic shock: a prospective interventional controlled study
Authors:
- S. V. MasolitinSMS. V. Masolitin
- D. N. ProtsenkoDPD. N. Protsenko
- M. A. MagomedovMMM. A. Magomedov
- E. M. ShifmanESE. M. Shifman
- I. N. TyurinITI. N. Tyurin
- B. Z. BelotserkovskiyBBB. Z. Belotserkovskiy
- L. A. GrishinaLGL. A. Grishina
- I. V. KolerovaIKI. V. Kolerova
- A. O. BykovABA. O. Bykov
- A. V. MarukhovAMA. V. Marukhov
- M. V. ZakharovMZM. V. Zakharov
- E. T. AbdullinEAE. T. Abdullin
Open Access
- 11 August 2025
- journal article
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Messenger of ANESTHESIOLOGY AND RESUSCITATION
- Vol. 22 (4) , 17-30
Abstract
Introduction. The use of extracorporeal blood purification (EBP) in septic shock (SS) complicated by acute kidney injury (AKI) remains a con troversial topic.The objective was to evaluate the effectiveness of EBP methods in patients with abdominal SS complicated by AKI.Materials and methods. Group 1 included 34 patients who received continuous veno-venous hemodiafiltration (CVVHDF) as emergency therapy. Group 2 consisted of 35 patients who underwent early isolated CVVHDF. Group 3 comprised 32 patients who received early combined EBP (selec tive plasma filtration + CVVHDF).Results. Combined EBP from day 1 to day 5 of therapy demonstrated a reduction in C-reactive protein from 223.5 to 140.9 mg/L (p = 0.001; −37.1%) compared to group 2 (219.7 to 179.2 mg/L; p = 0.004; −18.4%) and group 1 (214.5 to 189.3 mg/L; p = 0.772; −11.7%), as well as a decrease in interleukin-6 from 242.8 to 70.3 pg/mL (p = 0.001; −71.1%) vs. group 2 (233.7 to 123.4 pg/mL; p = 0.003; −47.2%) and group 1 (247.4 to 184.3 pg/mL; p = 0.512; −25.5%). Tumor necrosis factor levels decreased from 20.1 to 4.6 pg/mL (p = 0.001; −77.1%) in group 3, while group 2 showed a reduction from 19.4 to 11.9 pg/mL (p = 0.001; −38.7%) and group 1 exhibited minimal change (21.4 to 20.5 pg/mL; p = 0.525; −4.2%). Cystatin-C levels in group 3 decreased from 1.45 to 0.85 µg/mL (p = 0.048; −41.4%), whereas group 2 showed a slight reduction (1.6 to 1.5 µg/mL; p = 0.997; −6.3%) and group 1 demonstrated an increase (1.5 to 1.9 µg/mL; p = 0.027; +22.7%).Conclusions. Combined EBP significantly reduces inflammatory markers and improves kidney function compared to isolated renal replacement therapy, both in the early and delayed periods.Keywords
This publication has 37 references indexed in Scilit:
- Sepsis pathogenesis and outcome are shaped by the balance between the transcriptional states of systemic inflammation and antimicrobial responseCell Reports Medicine, 2024
- Stratification of Sepsis Patients on Admission into the Intensive Care Unit According to Differential Plasma Metabolic PhenotypesJournal of Proteome Research, 2024
- Timing of renal replacement therapy in patients with sepsis-associated acute kidney injury: A systematic review and meta-analysisAustralian Critical Care, 2023
- Extracorporeal blood purification therapies for sepsis-associated acute kidney injury in critically ill patients: expert opinion from the SIAARTI-SIN joint commissionJournal Of Nephrology, 2023
- Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trialThe Lancet, 2021
- Timing of Initiation of Renal-Replacement Therapy in Acute Kidney InjuryNew England Journal of Medicine, 2020
- Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease StudyThe Lancet, 2020
- Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney InjuryJAMA, 2016
- Developing a New Definition and Assessing New Clinical Criteria for Septic ShockJAMA, 2016
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016